• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 24

Substance: alpha-Amylase derived from Bacillus licheniformis carrying a gene encoding alpha-amylase from Bacillus stearothermophilus
Intended Use: Use in the starch industry (for the liquefaction of starch in the production of syrups) and in the alcohol industry (for the thinning of starch in distilling mashes) as a processing aid at minimum levels necessary to accomplish the intended technical effect in accordance with current good manufacturing practices
Basis: Scientific procedures
Notifier: Novo Nordisk
77 Perry Chapel Church Rd., Box 576; Franklinton, NC 27525
Date of filing: Jun 7, 1999
GRAS Notice (releasable information): 24
Date of closure / FDA's Letter: May 15, 2000
FDA has no questions